Hudson Bay Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Hudson Bay Capital Management's AMED Position: Q3 2025 in Review
Hudson Bay Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 197,126 shares — an estimated $19.4M sold.
Hudson Bay Capital Management first reported a position in AMED in Q4 2016 and held it in 13 quarters. The position peaked at $26.3M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Hudson Bay Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Hudson Bay Capital Management sold 197,126 Amedisys shares in Q3 2025, an estimated $19.4M.
- Hudson Bay Capital Management first reported a position in Amedisys in Q4 2016 and held it in 13 quarters.
- Hudson Bay Capital Management's Amedisys position peaked at $26.3M in Q2 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.